is microdosing glp 1 safer Does Ozempic or Other GLP-1s Really Lead to Weight Loss? Is It Safe to Microdose

A 2021 update on the use of liraglutide in the modern treatment of Diabesity: A Narrative Review

To view or add a comment, sign in In a major development for diabetes management and weight loss, Indias drug regulator Central Drugs Standard Control Organisation (CDSCO) has approved Ozempic (semaglutide) for use in adults with type 2 diabetes

A dose-dependent response has been observed with half (125 mg), normal (250 mg), and double (500 mg) doses, with higher doses producing greater blood sugar blunting effects

Approved injection sites Three areas are standard for subcutaneous peptide injections: Abdomen: The most common site

GLP-1 patches, on the other hand, are unregulated herbal supplements with very limited research behind them

CAROLYN BRAMANTE: I do think that many would access GLP-1s who don't currently